Femasys Inc. (FEMY)
FEMY moved a median of -0.39% 30 minutes after news, and -1.74% by the close. How FEMY actually reacts to news — the realized, point-in-time move the market made, measured across 279 labeled events over the last three years with zero look-ahead.
FEMY’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.45% | 36% | 277 |
| 30-min | -0.39% | 41% | 279 |
| 60-min | -0.86% | 39% | 279 |
| to close | -1.74% | 37% | 277 |
| Middle 50% of FEMY reactions | -3.61% to +1.53% |
|---|---|
| Median reaction (30-min) | -0.39% |
| Measured reactions | 279 |
Half of all Femasys Inc. news events land between -3.61% and +1.53% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when FEMY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to FEMY's baseline. Nothing else.
Recent FEMY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control | Press release | GlobeNewswire | — | -10.35% | |
| Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo | Press release | GlobeNewswire | -2.49% | +2.76% | |
| Form EFFECT FEMASYS INC | SEC filing · Form EFFECT | SEC EDGAR | -2.12% | -11.44% | |
| Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care | Press release | GlobeNewswire | +1.50% | -4.12% | |
| Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio | Press release | GlobeNewswire | -1.48% | +4.43% | |
| Form S-3 FEMASYS INC | SEC filing · Form S-3 | SEC EDGAR | +0.00% | -1.65% | |
| Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations | Press release | GlobeNewswire | -0.69% | +1.39% | |
| Form D FEMASYS INC | SEC filing · Form D | SEC EDGAR | +4.54% | +12.12% | |
| Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc® | Press release | GlobeNewswire | +19.59% | -8.45% | |
| Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update | Press release | GlobeNewswire | -0.88% | -5.26% | |
| Form 10-Q FEMASYS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.88% | -5.26% | |
| Form 8-K FEMASYS INC For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -0.88% | -5.26% | |
| Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents | Press release | GlobeNewswire | -3.65% | -9.62% | |
| Form 8-K FEMASYS INC For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -3.65% | -9.62% | |
| Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million | Press release | GlobeNewswire | -9.75% | -13.64% | |
| Femasys Regains Compliance with Nasdaq Listing Requirements | Press release | GlobeNewswire | -1.15% | -8.48% | |
| Form 8-K FEMASYS INC For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | — | -7.42% | |
| Form 8-K FEMASYS INC For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | -2.03% | -1.64% | |
| Form 8-K FEMASYS INC For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +4.05% | -8.95% | |
| Form 8-K FEMASYS INC For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.55% | +3.84% | |
| Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter | Press release | GlobeNewswire | -2.49% | -2.23% | |
| Form 8-K FEMASYS INC For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +0.36% | -0.91% | |
| Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update | Press release | GlobeNewswire | -4.23% | -6.00% | |
| Form 10-Q FEMASYS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.23% | -6.00% | |
| Form 8-K FEMASYS INC For: May 08 | SEC filing · Form 8-K | SEC EDGAR | -4.23% | -6.00% | |
| Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete | Press release | GlobeNewswire | +0.03% | +2.46% | |
| Form ARS FEMASYS INC For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +2.78% | +6.67% | |
| Form DEF 14A FEMASYS INC For: Jun 24 | SEC filing · Form DEF | SEC EDGAR | +2.78% | +6.67% | |
| Form DEFA14A FEMASYS INC | SEC filing · Form DEFA14A | SEC EDGAR | +2.78% | +6.67% | |
| Form 8-K FEMASYS INC For: Apr 29 | SEC filing · Form 8-K | SEC EDGAR | -1.08% | +1.44% | |
| Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 | Press release | GlobeNewswire | -2.38% | -2.33% | |
| Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio | Press release | GlobeNewswire | +0.37% | -2.09% | |
| Form DEF 14A FEMASYS INC For: Apr 29 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -6.72% | |
| Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth | Press release | GlobeNewswire | +0.58% | -3.58% | |
| Form 8-K FEMASYS INC For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | +0.58% | -3.58% | |
| Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update | Press release | GlobeNewswire | +0.58% | -3.58% | |
| Form 10-K FEMASYS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.58% | -3.58% | |
| Form 8-K FEMASYS INC For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | +0.58% | -3.58% | |
| Form S-8 FEMASYS INC | SEC filing · Form S-8 | SEC EDGAR | +0.58% | -3.58% | |
| Form PRE 14A FEMASYS INC For: Apr 29 | SEC filing · Form PRE | SEC EDGAR | -0.64% | -17.00% | |
| Form 8-K FEMASYS INC For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | -0.92% | -3.94% | |
| Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors | Press release | GlobeNewswire | +0.24% | +2.79% | |
| Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment | Press release | GlobeNewswire | +0.00% | +3.44% | |
| Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +3.70% | -0.37% | |
| Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access | Press release | GlobeNewswire | -1.70% | -5.37% | |
| Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination | Press release | GlobeNewswire | +0.00% | +1.74% | |
| Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products | Press release | GlobeNewswire | -0.41% | -2.75% | |
| Form 8-K FEMASYS INC For: Jan 13 | SEC filing · Form 8-K | SEC EDGAR | -2.69% | -5.54% | |
| Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement | Press release | GlobeNewswire | -0.33% | +17.95% | |
| Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care | Press release | GlobeNewswire | -0.85% | -0.73% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the FEMY section they belong to.
Where else FEMY is measured.
FEMY earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Femasys Inc.'s median reaction calculated?
Every labeled FEMY news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 279 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of FEMY's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does FEMY's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.